Gara Jalqabaatti › Kansera Urothelial (Cell Transitional) › Texas › Austin
Qorannoo klinikaalii Kansera Urothelial (Cell Transitional) Austin, TX keessatti
Qorannoo 10 Kansera Urothelial (Cell Transitional) f Austin fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Austin, Austin
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #46, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Namoota walitti qabaa jiraSadarkaa 3
- Texas Oncology, Austin
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Namoota walitti qabaa jiraSadarkaa 3
- USO-Texas Oncology-Central/South Texas, Austin
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Texas Urology Specialists-Austin, Austin
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology, Austin, Austin
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Namoota walitti qabaa jira
- Austin Urology Institute, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology, Austin, TX 78758
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Namoota walitti qabaa jiraSadarkaa 1
- Dren Investigational Site, Austin
Qorannoo Kansera Urothelial (Cell Transitional) magaalota biroo keessatti
- Nashville, TNQorannoo 23
- New York City, NYQorannoo 22
- Dallas, TXQorannoo 18
- Edison, NJQorannoo 18
- Houston, TXQorannoo 18
- Los Angeles, CAQorannoo 17
- Queens, NYQorannoo 15
- Chicago, ILQorannoo 14
- Arlington, VAQorannoo 12
- San Antonio, TXQorannoo 11
- Boston, MAQorannoo 11
- Orange, CAQorannoo 10
Qorannoo biroo Austin keessatti
- Kansara Qara'a Non-Small CellQorannoo 30
- Saree (Gosoota Hunda)Qorannoo 20
- ObesityQorannoo 20
- Kansara MetastatikiiQorannoo 19
- Kansarii ColorectalQorannoo 19
- Cufama OnneeQorannoo 18
- Saree OljooQorannoo 18
- Baayyee UlfaataaQorannoo 18
- Kansarii OvariiQorannoo 17
- Kansa EndometiriyaaliiQorannoo 15
- Kansarii ProstateQorannoo 15
- DepreshiniiQorannoo 14
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.